The Power and Promise of Patient-Derived Xenografts of Human Breast Cancer
{{output}}
In 2016, a group of researchers engaged in the development of patient-derived xenografts (PDXs) of human breast cancer provided a comprehensive review of the state of the field. In that review, they summarized the clinical problem that PDXs might address, the ... ...
